AB
Ansa Biotechnologies, Inc.
SEC filingBiotechnology · Emeryville, CA
Amount raised$46.4Msold at filing
Total offering$56.9M$10.5M still open
Investors in the raise41count reported to the SEC
FiledDec 10, 2025first sale Jun 28, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jason T. GammackExecutive Officer, Director
Yanniv T. DoroneDirector
Daniel T. Lin-ArlowExecutive Officer, Director
Chenny T. ZhangDirector
Matthew T. McManusDirector
Sebastian T. PallukExecutive Officer
Executive officers, directors and promoters as listed on the Form D.